Suchergebnisse

• (0:20) - Should Investors Be Concerned About An Incoming Recession?
• (19:45) - Where Should Be Looking To Invest Right Now?
• (38:15) - Episode Roundup: ARW, MKSI, MWH, TSM, CAT, AMZN
•                

Brinker International, Inc. EAT expects another year of revenue and earnings growth in fiscal 2027, helped by an unusual 53rd operating week. The calendar benefit is meaningful, but it is only one

Quanta Services (PWR) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue

Snail, Inc. SNAL saw bookings fall 19.6% year over year to $21.8 million in the second quarter of 2026. The decline was mainly caused by lower sales of ARK: Survival Evolved (“ASE”) and ARK

Investors in Colony Bankcorp, Inc. CBAN need to pay close attention to the stock based on moves in the options market lately. That is because the January 15, 2026 $05.00 Call had some of the highest

AbbVie’s ABBV neuroscience franchise continued to deliver strong growth in the first half of 2026, with sales reaching $6.1 billion, up 21.8% year over year on an operational basis. While the

Prudent pricing, increasing climate-related risks and rapid digital transformation are likely to influence the insurance industry’s outlook in 2026. Although insurers remain exposed to catastrophe

Sprouts Farmers Market, Inc. SFM delivered a mixed second quarter as new-store productivity supported sales growth while comparable-store sales remained soft. Earnings per share came in above the

American States Water Company AWR continues to reward shareholders through regular dividend payments and consistent annual dividend increases. Its long-standing dividend record reflects the strength

Bristol Myers Squibb BMY recently announced that the FDA has granted accelerated approval to iberdomide in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd).

The regimen